Literature DB >> 25547151

MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.

Xianzhao Deng1, Bo Wu, Ke Xiao, Jie Kang, Jing Xie, Xiaoping Zhang, Youben Fan.   

Abstract

BACKGROUND/AIMS: Micro-RNA (miR)-146b-5p is overexpressed in papillary thyroid carcinoma (PTC) and associated with extrathyroidal invasion and advanced tumor stage. In the present study, we showed that miR-146b-5p is upregulated in PTC with lymph node metastasis.
METHODS: A computational search and luciferase assay identified zinc RING finger 3 (ZNRF3), a negative regulator of Wnt/β-catenin signaling, as a direct target of miR-146b-5p in PTC.
RESULTS: MiR-146b-5p promoted migration and invasiveness and induced epithelial-mesenchymal transition (EMT) of PTC cells, whereas ZNRF3 overexpression reversed this effect. MiR-146b-5p increased the cell surface levels of the Wnt receptors Frizzled-6 and LRP6 and enhanced Wnt/β-catenin signaling by downregulating ZNRF3, whereas an inhibitor of Wnt/β-catenin suppressed the effect of miR-146b-5p on migration, invasiveness and EMT of PTC cells.
CONCLUSION: These results indicate that miR-146b-5p induces EMT and may promote PTC metastasis through the regulation of Wnt/β-catenin signaling, and suggest novel potential therapeutic targets for the treatment of PTC.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25547151     DOI: 10.1159/000369676

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  60 in total

1.  Effects of radiotherapy on nasopharyngeal carcinoma cell invasiveness.

Authors:  Zheng Peng; Tiancai Xu; Xiaofang Liao; Huijuan He; Wansu Xu
Journal:  Tumour Biol       Date:  2015-08-29

2.  MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.

Authors:  Sophie Baumgart; Pascal Meschkat; Philipp Edelmann; Joana Heinzelmann; Alexey Pryalukhin; Rainer Bohle; Julia Heinzelbecker; Michael Stöckle; Kerstin Junker
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-24       Impact factor: 4.553

3.  Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b.

Authors:  Lei Chen; Lei Xu; Gang Wang
Journal:  Tumour Biol       Date:  2015-06-06

4.  Thyroid carcinoma cells produce PLGF to enhance metastasis.

Authors:  Junyi He; Na Shen; Xinsheng Huang
Journal:  Tumour Biol       Date:  2015-06-04

5.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

Review 6.  Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.

Authors:  Hao-Feng Gu; Xue-Ying Mao; Min Du
Journal:  Crit Rev Food Sci Nutr       Date:  2019-01-11       Impact factor: 11.176

7.  PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition.

Authors:  Siming Yu; Linna Li; Wei Tian; Dan Nie; Wei Mu; Fang Qiu; Yu Liu; Xinghan Liu; Xiaofeng Wang; Zhimin Du; Wen-Feng Chu; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

8.  miR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer.

Authors:  Yuanzeng Zhu; Gang Wu; Wenfeng Yan; Han Zhan; Peichun Sun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

Review 9.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

10.  ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.

Authors:  Wangwang Qiu; Zhili Yang; Youben Fan; Qi Zheng
Journal:  Tumour Biol       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.